Anika Therapeutics (ANIK) Research & Development: 2010-2025
Historic Research & Development for Anika Therapeutics (ANIK) over the last 15 years, with Sep 2025 value amounting to $6.9 million.
- Anika Therapeutics' Research & Development rose 16.82% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 64.54%. This contributed to the annual value of $25.5 million for FY2024, which is 17.37% up from last year.
- Anika Therapeutics' Research & Development amounted to $6.9 million in Q3 2025, which was up 10.03% from $6.3 million recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Research & Development registered a high of $8.9 million during Q2 2023, and its lowest value of -$3.3 million during Q4 2023.
- Moreover, its 3-year median value for Research & Development was $6.5 million (2024), whereas its average is $6.1 million.
- As far as peak fluctuations go, Anika Therapeutics' Research & Development tumbled by 135.20% in 2022, and later surged by 294.70% in 2024.
- Quarterly analysis of 5 years shows Anika Therapeutics' Research & Development stood at $6.0 million in 2021, then tumbled by 135.20% to -$2.1 million in 2022, then plummeted by 58.24% to -$3.3 million in 2023, then soared by 294.70% to $6.5 million in 2024, then climbed by 16.82% to $6.9 million in 2025.
- Its last three reported values are $6.9 million in Q3 2025, $6.3 million for Q2 2025, and $6.1 million during Q1 2025.